HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Stock Information for Heart Test Laboratories Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Heart Test Laboratories Inc.

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
HeartSciences to Present at the LD Micro Invitational XIV Conference
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
HeartSciences Adds Key Advisor to its Scientific Advisory Board
HeartSciences Expands its Scientific Advisory Board
HeartSciences Appoints New Scientific Advisory Board Member

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.